Redmile Group, LLC - 31 Dec 2025 SCHEDULE 13G/A Report for ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
ADC Therapeutics SA Common Shares, par value CHF 0.08 per share
Symbol
ADCT
Shares outstanding
123,360,087 shares
Disclosed Ownership
15,666,731 shares
Ownership
13%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:15:07 UTC
Date of event
31 Dec 2025
Previous filing
14 Aug 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 13% 15,666,731 0 15,666,731 /s/ Jeremy C. Green Managing Member
Jeremy C. Green 13% 15,666,731 0 15,666,731 /s/ Jeremy C. Green Jeremy C. Green
RedCo II Master Fund, L.P. 11% 13,145,712 0 13,145,712 /s/ Jeremy C. Green Managing Member of RedCo II (GP), LLC, General Partner of RedCo II Master Fund, L.P.